当前位置:主页 > 医学论文 > 药学论文 >

罕见病研究与孤儿药开发刻不容缓

发布时间:2019-04-03 07:39
【摘要】:正罕见病是指患者人数较少,患病率极低的疾病的统称。世界各国根据自己国家的具体情况,对罕见病的认定标准存在一定的差异。例如,美国将每年患病人数少于20万人,大约是发病人口比例小于1/1500的疾病定义为罕见病。日本是1/2500,欧洲的标准是1/2000。中国目前还没有具体的规定,目前常见的罕见病有以下几种。
[Abstract]:Positive rare disease refers to the small number of patients and very low prevalence of the disease. According to the specific conditions of their own countries, there are some differences in the standards of identification of rare diseases in the world. The United States, for example, defines less than two hundred thousand people a year, or less than 1 / 1, 500, as a rare disease. Japan is 1, 500, Europe's standard is 1-2, 000. There are no specific regulations in China, and the common diseases are as follows.
【分类号】:R95


本文编号:2453034

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2453034.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户521aa***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com